Navigation Links
Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins

ANN ARBOR, Mich., June 1 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life science and translational research markets, has announced the release of the first commercially available multiplex assay dedicated to the analysis of heat shock proteins and molecular chaperones, the MultiBead(TM)* HSP/Chaperone 8-Plex Kit.

The bead-based multiplex immunoassay enables measurement of HSP client proteins (Akt and Akt phosphor-Ser473) and HSPs (Hsp27 phospho Ser15, Hsp27 phospho-Ser82, Hsp40, Hsp60, Hsp70 and Hsp90 alpha) in cell lysates. The assay utilizes monoclonal antibodies or antigen affinity purified polyclonal antibodies covalently coupled to latex beads. The detection antibodies are conjugated to biotin followed by a streptavidin-PE conjugate and analyzed on a dual-laser flow cytometer. The HSP/Chaperone panel provides a sensitive, rapid and specific method for accurately determining analyte levels in cell lysates.

"This new multiplex research tool builds on our core competency as a leader in cellular stress research, which was solidified with our acquisition of Stressgen Bioreagents in 2005," stated Mike Vespremi, Product Manager for Assay Designs. "Building on that expertise we've created a multiplex panel with specific benefits for many of our core customers where one had not previously existed."

The MultiBead technology, which already has products for inflammatory markers, is a major focus for Assay Designs research and development department and several additional panels are expected to launch this calendar year.

Additionally, Assay Designs has made available a complete update of the MultiBead Analysis Software in releasing version 2.0. This newest iteration of the MultiBead software has a more intuitive and graphical interface which complements additional features including the usage of dot-density scatter plots, the ability to change and recalculate experimental parameters in real time, and more extensive result reporting with customizable data output. The new software package also allows the user to create experimental templates for streamlining analysis of similar experiments, as well as the ability to save progress at defined points in the analysis so it can be completed or recalculated at another time. MultiBead Analysis Software v2.0 (PC and Mac versions) is available for download at no charge to customers from the Assay Designs website.

About Assay Designs, Inc. (now an Enzo Life Sciences company)

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the Assay Designs and Stressgen(R) brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress. New assay platforms include MultiBead(TM)* bead-based multiplex immunoassay kits and ImmunoSet(TM) ELISA development reagents.

*MultiBead is Reg. U.S. Pat. & TM. Office

SOURCE Assay Designs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
2. AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1
3. BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
4. Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
5. Polycystic Kidney Disease Assay at Cornell University Uses Transgenomics Surveyor Nuclease & WAVE Technology
6. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
7. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
8. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
9. SAFC Pharma Augments Assay Development Capabilities
10. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
11. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):